Weiru Wang
Impact in
- Molecular Biology top 2%
- Protein Kinase Regulation and GTPase Signaling
- TGF-β signaling in diseases
- Biochemical and Molecular Research
- Melanoma and MAPK Pathways
- Protein Structure and Dynamics
- Cancer-related gene regulation
- Geriatrics and Gerontology top 2%
Papers in
-
- Protein Kinase Regulation and GTPase Signaling 12
- Melanoma and MAPK Pathways 9
- Biochemical and Molecular Research 9
- Oncology 15
- Peptidase Inhibition and Analysis 4
- Co-authors
- Sung‐Hou Kim (7 shared papers)Guowei Fang (3 shared papers)Rosalind Kim (8 shared papers)Hisao Yokota (7 shared papers)Joachim Rudolph (10 shared papers)Jaru Jancarik (4 shared papers)Kunxin Luo (1 shared paper)David Y. Chen (1 shared paper)
- Journals
- Proceedings of the National Academy of Sciences (9 papers)Bioorganic & Medicinal Chemistry Letters (6 papers)Journal of Medicinal Chemistry (5 papers)Structure (4 papers)ACS Medicinal Chemistry Letters (3 papers)
- Partner nations
- United StatesFranceChina
In The Last Decade
Weiru Wang
67 papers receiving 3.8k citations
Weiru Wang's Hit Papers
Peers
Comparison fields: 5 of 124
- Molecular Biology 2.9k
- Geriatrics and Gerontology 100
- Oncology 670
- Cell Biology 341
- Physiology 92
Countries citing papers authored by Weiru Wang
This map shows the geographic impact of Weiru Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiru Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiru Wang more than expected).
Fields of papers citing papers by Weiru Wang
This network shows the impact of papers produced by Weiru Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiru Wang. The network helps show where Weiru Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Weiru Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 68 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Small-molecule ligands bind to a distinct pocket in Ras and inhibit SOS-mediated nucleotide exchange activity Hit paper breakdown → | 2012 | 486 |
| 2 | 1999 | 379 | |
| 3 | 2011 | 215 | |
| 4 | 2011 | 188 | |
| 5 | 2002 | 161 | |
| 6 | 2013 | 157 | |
| 7 | 2011 | 135 | |
| 8 | 2002 | 129 | |
| 9 | 2005 | 126 | |
| 10 | 2001 | 126 | |
| 11 | 2001 | 119 | |
| 12 | 2015 | 97 | |
| 13 | 2016 | 93 | |
| 14 | 2000 | 91 | |
| 15 | 2014 | 90 | |
| 16 | 2017 | 89 | |
| 17 | 2012 | 83 | |
| 18 | 2001 | 82 | |
| 19 | 2018 | 67 | |
| 20 | 2006 | 62 |
About Weiru Wang
Weiru Wang is a scholar working on Molecular Biology, Oncology, Materials Chemistry, Organic Chemistry and Epidemiology, having authored 68 papers that have together received 3.9k indexed citations. Recurring topics across this work include Protein Kinase Regulation and GTPase Signaling (12 papers), Enzyme Structure and Function (11 papers), Melanoma and MAPK Pathways (9 papers), Biochemical and Molecular Research (9 papers), Computational Drug Discovery Methods (5 papers), Sirtuins and Resveratrol in Medicine (5 papers), Cancer Mechanisms and Therapy (4 papers) and Peptidase Inhibition and Analysis (4 papers). The work is most often cited by research in Molecular Biology (2.9k citations), Geriatrics and Gerontology (100 citations), Oncology (670 citations), Cell Biology (341 citations) and Physiology (92 citations). Weiru Wang has collaborated with scholars based in United States, France and China. Frequent co-authors include Sung‐Hou Kim, Guowei Fang, Rosalind Kim, Hisao Yokota, Joachim Rudolph, Jaru Jancarik, Kunxin Luo, David Y. Chen, Eric Martens and S. Zhou. Their work appears in journals such as Proceedings of the National Academy of Sciences, Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, Structure and ACS Medicinal Chemistry Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.